NEXTGEN HEALTHCARE,

NXGN
Real-time Estimate Quote. Real-time Estimate  - 07/15 02:44:45 pm
11.315USD +5.55%
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: March 2020 2021
Net sales1 540512
EBITDA1 10284,5
Operating profit (EBIT)1 5,111,40
Operating Margin 0,95%0,27%
Pre-Tax Profit (EBT)1 4,262,44
Net income1 7,50-3,94
Net margin 1,39%-0,77%
EPS2 0,11-0,05
Dividend per Share2 --
Last update 06/01/202007/14/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: March 2020 2021
Net Debt1 --
Net Cash position1 9,01118
Leverage (Debt / EBITDA) -0,09x-1,40x
Free Cash Flow1 58,724,6
ROE (Net Profit / Equities) 14,1%3,82%
Shareholders' equity1 53,3-103
ROA (Net Profit / Asset) 1,20%0,37%
Assets1 627-1 064
Book Value Per Share2 6,065,97
Cash Flow per Share2 1,300,82
Capex1 26,924,8
Capex / Sales 4,98%4,83%
Last update 06/01/202006/25/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Financial Ratios
Size 2021e 2022e
Capitalization 715 M $ -
Entreprise Value (EV) 597 M $ 603 M $
Valuation 2021e 2022e
P/E ratio (Price / EPS) -199x 116x
Capitalization / Revenue 1,40x 1,30x
EV / Revenue 1,16x 1,09x
EV / EBITDA 7,06x 6,13x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 1,80x 1,77x
Profitability 2021e 2022e
Operating Margin (EBIT / Sales) 0,27% 3,15%
Operating Leverage (Delta EBIT / Delta Sales) -14,1x x
Net Margin (Net Profit / Revenue) -0,77% 1,14%
ROA (Net Profit / Asset) 0,37% 0,40%
ROE (Net Profit / Equities) 3,82% 7,78%
Rate of Dividend - -
Balance Sheet Analysis 2021e 2022e
CAPEX / Sales   4,83% 4,89%
Cash Flow / Sales 10,7% 9,22%
Capital Intensity (Assets / Sales) -2,08x 2,84x
Financial Leverage (Net Debt / EBITDA) - -
Price Earning Ratio
EPS & Dividend